"This product [distributed in the US] is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losartan, USP manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. Sandoz Inc. Losartan Potassium Hydrochlorothiazide product is manufactured by Lek Pharmaceuticals dd, Ljubljana, Slovenia. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC). ... The product can be identified as Losartan Potassium Hydrochlorothiazide, 100 mg/25 mg tablets in 1000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912; Exp. Date 06/2020. This product was distributed nationwide to distributors. The affected product was not distributed prior to October 8, 2018."
https://www.fda.gov/Safety/Recalls/ucm625492.htm
Sandoz recalls Losartan Potassium Hydrochlorothiazide
-
Lindy
- Contributor
- Posts: 70
- Joined: Mon Feb 05, 2018 9:06 pm
- Location: The beautiful Pacific Northwest USA
Sandoz recalls Losartan Potassium Hydrochlorothiazide
APOE-ε4/ε4 on the voyage of discovery.
